MTOR and Parkinson disease: In experimental PD, this phenomenon leads to the hyperactivation of multiple signaling pathways, including the cAMP, extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin (mTOR) cascades, ultimately resulting in long-term modifications of gene expression and protein synthesis.